CHS Inc.
NASDAQCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Jay Debertin
- Full Time Employees
- 10,683
- Sector
- Consumer Defensive
- Industry
- Packaged Foods
- Address
- 5500 Cenex Drive Inver Grove Heights MN United States of America 55077
- IPO Date
- Jan 15, 2015
- CIK
- 0000823277
- Website
- chsinc.com
- Similar Companies
- Business
- CHS Inc. is a diversified global agribusiness cooperative owned by farmers, ranchers, and member cooperatives across the United States, providing energy, agronomy, grains, foods, and related services to agricultural producers and customers worldwide. Founded in 1931 and headquartered in Inver Grove Heights, Minnesota, the company operates extensive supply chains, grain elevators, petroleum refineries, pipelines, and retail networks in more than 450 U.S. communities, serving markets in 65 countries through domestic and international operations. CHS offers a broad portfolio of products and services, including Cenex-brand refined fuels, lubricants, propane, and renewable energy products; crop nutrients, fertilizers, crop protection products, seeds, and precision agronomy solutions; grain origination, marketing, and trading; animal nutrition and feed; food processing and ingredients such as vegetable oils via its co-ownership of Ventura Foods with Mitsui & Co.; financial and risk management services; and insurance solutions. The company maintains business segments in energy, with refining and distribution supporting rural operations; nitrogen production through its CF Nitrogen joint venture with CF Industries; and corporate operations encompassing strong contributions from food ventures. In recent developments, CHS reported fiscal year 2025 net income of $597.9 million on revenues of $35.5 billion, down from prior year levels due to lower commodity prices, narrower refining margins, and market challenges, yet announced plans to return $120 million in cash patronage and equity redemptions to owners in calendar year 2026, marking nearly $2.6 billion returned over five years; operational highlights included resilient ag volumes in crop protection and nutrients alongside nitrogen production gains.
Comprehensive Healthcare Systems Wins Teamsters Union Benefits Administration Contract
Comprehensive Healthcare Announces Participation in the IFEBP Conference and Confirms Previously Announced Shares for Debt Settlement
CORRECTING and REPLACING CHS Reports Second Quarter Fiscal Year 2026 Earnings
CHS Reports Second Quarter Fiscal Year 2026 Earnings
Join Comprehensive Healthcare Systems' Exclusive Live Investor Webinar and Q&A Session on February 25
Comprehensive Healthcare Systems Inc. Engages RedChip Companies to Lead Investor Relations Efforts
CHS Reports First Quarter Fiscal 2026 Earnings
Coherus Oncology Announces Publication in Molecular Cancer Therapeutics Highlighting the Strong Pharmacology of Investigational CCR8 Antibody Tagmokitug (CHS-114)
Coherus Oncology: Five Readouts Or More Possible In 2026
Comprehensive Healthcare Systems Inc. Begins Trading on the OTCQB Markets Under the Symbol CMHSF
Comprehensive Healthcare Systems Q2 Update: Leading Healthcare Innovation with Robust Growth and Strategic Vision
Coherus BioSciences Reports First Quarter 2025 Financial Results and Provides Business Update
Coherus Presents Promising Early Clinical Data from Phase 1 Dose Expansion Study of CHS-114 in Patients with Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma at AACR 2025
Coherus to Present Data from a Phase 1 Dose Expansion Study of CHS-114, a Cytolytic Antibody Targeting Chemokine Receptor 8 (CCR8), at the 2025 American Association for Cancer Research (AACR) Annual Meeting
Community Health Systems and Denim Health Announce a Development Partnership Designed to Broadly Scale Conversational AI Across the CHS Patient Access Center